Waheed Nadia Insider Trades

Insider Trading History

Track insider trading activity for Waheed Nadia. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ocular Therapeutix
Ocular Therapeutix OCUL
Chief Medical Officer
Holding Value $2.63M 314,907 shares
Last Trade
Feb 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.2k 3,510 shares
$7.74
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Chief Medical Officer
Holding Value $2.66M 318,417 shares
Last Trade
Feb 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$71.1k 7,863 shares
$9.04
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Chief Medical Officer
Holding Value $2.72M 326,280 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.78M 320,044 shares
$11.82
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Chief Medical Officer
Holding Value $2.06M 247,168 shares
Last Trade
Aug 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.53M 122,923 shares
$12.48
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Chief Medical Officer
Holding Value $1.73M 206,805 shares
Last Trade
Jun 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$112k 13,861 shares
$8.05
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Chief Medical Officer
Holding Value $1.98M 237,000 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.76M 237,000 shares
$7.44
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Chief Medical Officer
Holding Value $3.55M 425,000 shares
Last Trade
Jun 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42M 425,000 shares
$5.70
$8.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up